Index of reports
> Cases with Deep Vein Thrombosis ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include deep vein thrombosis. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of Next >>
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-13
Patient:
Reactions: Pulmonary Embolism, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Somnolence, Death, Complications of Transplant Surgery, Peripheral Motor Neuropathy, Thrombosis in Device, Blood Alkaline Phosphatase Increased, Pancytopenia, Multiple Fractures, Rash, Renal Failure, Osteonecrosis of JAW, Embolism, Hypothyroidism, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Thalidomide
Dosage: or 4 weeks and increased every 4 weeks in 50-mg increments to a maximum of 200mg/day
Administration route: Oral
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Dosage: 20 milligram
Indication: Multiple Myeloma
Other drugs received by patient: Melphalan Hydrochloride; Prednisolone; CLO; ZOL; Melphalan Hydrochloride; Biphosphonate; Vincristine; Doxorubicin Hydrochloride; Bortezomib
Possible Dexamethasone side effects in
Reported by a physician from Italy on 2012-08-03
Patient:
Reactions: Pyrexia, Constipation, Disease Progression, Liver Disorder, Herpes Zoster, Cardiac Disorder, Death, Neuropathy Peripheral, Oedema, Thrombocytopenia, Hyperglycaemia, Toxicity To Various Agents, Rash, Gastrointestinal Disorder, Pancreatitis, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Bortezomib
Dosage: 1.3 milligram/sq. meter
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Thalidomide
Dosage: 200 milligram
Administration route: Oral
Thalidomide
Dosage: 50 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Dexamethasone
Dosage: 40 milligram
Bortezomib
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Bortezomib
Dosage: 1 milligram/sq. meter
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Dexamethasone
Dosage: 40 milligram
Bortezomib
Dosage: .7 milligram/sq. meter
Thalidomide
Dosage: 100 milligram
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Acyclovir; Melphalan Hydrochloride; Neupogen; Neupogen; Cyclophosphamide
Possible Dexamethasone side effects in
Reported by a individual with unspecified qualification from Spain on 2012-07-30
Patient:
Reactions: Colon Cancer, Pulmonary Embolism, Toxicity To Various Agents, Multiple Myeloma, Herpes Zoster, Death, Neuropathy Peripheral, Gastrointestinal Disorder, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bortezomib
Dosage: 1.3mg/m2 on days 1,4,8 and 11 q 3 weeks
Indication: Multiple Myeloma
Thalomid
Dosage: 200mg daily (escalating doses in the first cycle)
Administration route: Oral
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40mg on days 1-4 and 9-12 at 4-week intervals
Administration route: Oral
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18
Patient:
Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Velcade
Dosage: 1.3 milligram/sq. meter
Indication: Multiple Myeloma
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Revlimid
Dosage: 15 milligram
Administration route: Oral
Cyclophosphamide
Dosage: 500 milligram/sq. meter
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 milligram/sq. meter
Dexamethasone
Dosage: 40 milligram
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-07-16
Patient:
Reactions: Graft Versus Host Disease, Pulmonary Embolism, Toxicity To Various Agents, Polyneuropathy, Disease Progression, Death, Embolism Venous, Deep Vein Thrombosis
Adverse event resulted in: death
Drug(s) suspected as cause:
Thalomid
Dosage: induction therapy, 200 mg escalated to 400 mg, qd, with vte prophylaxis
Administration route: Oral
Indication: Multiple Myeloma
Melphalan Hydrochloride
Dosage: 200 milligram/sq. meter
Cyclophosphamide
Dosage: 1000 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Adriamycin PFS
Dosage: 15 milligram/sq. meter
Thalomid
Dosage: maintenance therapy, 50 mg qd, without vte prophylaxis
Administration route: Oral
Adriamycin PFS
Dosage: 9 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen; Mycophenolate Mophetil; Cyclosporine; Nadroparine
Possible Dexamethasone side effects in 46 year old male
Reported by a physician from United States on 2012-07-12
Patient: 46 year old male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituxan
Dosage: 698 mg, unk
Start date: 2012-05-02
Mesna
Dosage: 1116 mg, unk
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: 446 mg, unk
Doxorubicin HCL
Dosage: 56.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Pegfilgrastim
Dosage: 6 mg, unk
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: 630 mg, q12h
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine Sulfate
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Doxorubicin HCL
Dosage: 37 mg, unk
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
Rituxan
Dosage: 787.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Other drugs received by patient: MS Contin; Valtrex; Omeprazole; Ciprofloxacin; Morphine Sulfate; Enoxaparin / 01708202 /; Compazine; Fluconazole; Metoprolol Tartrate
Possible Dexamethasone side effects in 83 year old male
Reported by a physician from United States on 2012-07-10
Patient: 83 year old male
Reactions: Rectal Cancer, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 25mg daily for days 1-21 or 15mg daily
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-08-02
Dexamethasone
Dosage: 40mg once a week days 1,8,15,22/ 20mg once a week days 1,8,15,22
Indication: Multiple Myeloma
Start date: 2011-08-02
Other drugs received by patient: Meloxicam; Zometa
Possible Dexamethasone side effects in 46 year old male
Reported by a physician from United States on 2012-07-09
Patient: 46 year old male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Neulasta
Doxorubicin HCL
Vincristine
Neulasta
Indication: non-Hodgkin's Lymphoma
Mabthera
Start date: 2012-05-02
Mabthera
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine
Indication: non-Hodgkin's Lymphoma
Mesna
Cyclophosphamide
Dexamethasone
Administration route: Oral
Mesna
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Valtrex; Omeprazole; Fluconazole; Metoprolol; Morphine; Ciprofloxacin; MS Contin; Enoxaparin; Compazine
Possible Dexamethasone side effects in
Reported by a physician from Italy on 2012-06-29
Patient:
Reactions: Anaemia, Febrile Neutropenia, Rash, Multiple Myeloma, Pyrexia, Stem Cell Transplant, Myeloma Recurrence, Neuropathy Peripheral, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: 300 milligram/sq. meter
Indication: Multiple Myeloma
Dexamethasone
Dosage: 20 milligram
Indication: Multiple Myeloma
Possible Dexamethasone side effects in 48 year old male
Reported by a health professional (non-physician/pharmacist) from Turkey on 2012-06-22
Patient: 48 year old male
Reactions: Plasmacytoma, Osteonecrosis, Staphylococcal Abscess, Deep Vein Thrombosis, RIB Fracture, Disease Progression
Drug(s) suspected as cause:
Lenalidomide
Dosage: 25 mg
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Dexamethasone
Dosage: 40 mg
Indication: Multiple Myeloma
Dexamethasone
Thalidomide
Dosage: 200 mg
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Aspirin
Indication: Thrombosis Prophylaxis
Zoledronoc Acid
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a physician from Turkey on 2012-06-13
Patient:
Reactions: Osteonecrosis, Staphylococcal Abscess, RIB Fracture, Deep Vein Thrombosis, Disease Progression
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 unk, unk
Dexamethasone
Dosage: 40 mg, cyclic
Administration route: Oral
Indication: Multiple Myeloma
Velcade
Dosage: 1.3 mg/m2, cyclic
Indication: Multiple Myeloma
Cyclophosphamide
Dosage: 750 mg/m2, cyclic
Indication: Multiple Myeloma
Lenalidomide
Dosage: 25 mg, cyclic
Indication: Multiple Myeloma
Possible Dexamethasone side effects in
Reported by a physician from Greece on 2012-05-08
Patient:
Reactions: Sudden Death, Orthostatic Hypotension, Constipation, Myalgia, Neuropathy Peripheral, Fatigue, Oedema Peripheral, Hypocalcaemia, Acute Myocardial Infarction, Blood Creatinine Increased, Thrombocytopenia, Hypotension, Hyponatraemia, Rash, Cerebrovascular Accident, Renal Impairment, Diarrhoea, Amyloidosis, Neutropenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Dosage: 15 milligram
Administration route: Oral
Dexamethasone
Dosage: 20 milligram
Indication: Amyloidosis
Cyclophosphamide
Dosage: level 0: 50mg, level 1-4: 100mg
Indication: Amyloidosis
Revlimid
Dosage: level 0-1: 10mg, level 2: 15mg, level 3: 20mg, level 4: 25mg
Administration route: Oral
Indication: Amyloidosis
Revlimid
Dosage: 15 milligram
Administration route: Oral
Other drugs received by patient: Aspirin
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-04-23
Patient: male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Pegfilgrastim
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 56.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Cyclophosphamide
Dosage: 630 mg, q12h
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Rituximab
Dosage: 787.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Other drugs received by patient: Metoprolol Tartrate; MS Contin; Fluconazole; Valtrex; Ciprofloxacin
Possible Dexamethasone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-04-18
Patient: male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Doxorubicin Hydrochloride
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Mabthera
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Neulasta
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Metoprolol Tartrate; Fluconazole; Valtrex; Ciprofloxacin Hydrochloride; MS Contin
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-04-17
Patient: male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Doxorubicin HCL
Dosage: 56.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Rituximab
Dosage: 787.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Cyclophosphamide
Dosage: 630 mg, q12h
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Pegfilgrastim
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Ciprofloxacin Hydrochloride; Fluconazole; MS Contin; Valtrex; Metoprolol
Possible Dexamethasone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-04-10
Patient: male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Neulasta
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Other drugs received by patient: Fluconazole; Valtrex; Metoprolol Tartrate; Ciprofloxacin Hydrochloride; MS Contin
Possible Dexamethasone side effects in male
Reported by a physician from France on 2012-04-04
Patient: male
Reactions: Basal Cell Carcinoma, Deep Vein Thrombosis
Drug(s) suspected as cause:
Lenalidomide
Dosage: 25 milligram
Administration route: Oral
Start date: 2012-03-01
Dexamethasone
Indication: Multiple Myeloma
Start date: 2008-12-10
End date: 2010-01-06
Lenalidomide
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2008-12-10
Other drugs received by patient: Omeprazole; Zopiclone; Moviprep; Acetaminophen and Tramadol HCL; Enalapril; Enalapril Maleate; Acetaminophen; Oracillin; Previscan
Possible Dexamethasone side effects in
Reported by a health professional (non-physician/pharmacist) from China on 2012-04-02
Patient:
Reactions: Vomiting, Anaemia, Pyrexia, Multiple Myeloma, Constipation, Herpes Zoster, Neuropathy Peripheral, Fatigue, Diarrhoea, Upper Respiratory Tract Infection, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis
Drug(s) suspected as cause:
Thalidomide
Dosage: initial dose
Administration route: Oral
Doxorubicin HCL
Dosage: continuous infusion of days 1-4
Indication: Multiple Myeloma
Thalidomide
Dosage: mtd 9maximum tolerated dose
Administration route: Oral
Indication: Multiple Myeloma
Dexamethasone
Dosage: on days 1-4, 9-12 and 17-20, montly minimum of 4 cycles and maximum of 6 cycles
Administration route: Oral
Indication: Multiple Myeloma
Vincristine
Dosage: continuous infusion on days 1-4
Indication: Multiple Myeloma
Other drugs received by patient: Aspirin
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-03-28
Patient: male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, unk
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Cyclophosphamide
Dosage: 630 mg, q12h
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Pegfilgrastim
Indication: non-Hodgkin's Lymphoma
Doxorubicin HCL
Dosage: 56.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Rituximab
Dosage: 787.5 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Other drugs received by patient: Valtrex; Fluconazole; Ciprofloxacin; Metoprolol Succinate; MS Contin
Possible Dexamethasone side effects in 56 year old male
Reported by a pharmacist from United States on 2012-03-23
Patient: 56 year old male, weighing 93.8 kg (206.4 pounds)
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 mg, weekly
Indication: Multiple Myeloma
Start date: 2011-11-10
Revlimid
Dosage: 25 mg, 1 in 1 d, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-11-10
Other drugs received by patient: Acyclovir; Fentanyl; Gabapentin; Ativan; Nexium; Ambien; Fragmin (Heparin-F-Ractino, Sodium Salt); MLN-9708 (Protease Inhibitors); Bactrim SS (Bactrim); Multivitamin; Vicodin
Possible Dexamethasone side effects in 77 year old male
Reported by a physician from United States on 2012-03-23
Patient: 77 year old male, weighing 61.2 kg (134.7 pounds)
Reactions: NO Therapeutic Response, Multiple Myeloma, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Start date: 2011-04-01
Revlimid
Dosage: 10 mg, 1 in 1 d, po, 25 mg, daily for 14 days, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-04-26
Revlimid
Dosage: 10 mg, 1 in 1 d, po, 25 mg, daily for 14 days, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-08-16
End date: 2011-04-16
Other drugs received by patient: Velcade; Aspirin
Possible Dexamethasone side effects in 61 year old male
Reported by a physician from United States on 2012-03-23
Patient: 61 year old male
Reactions: Pulmonary Embolism, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Start date: 2011-08-24
Revlimid
Dosage: 25 mg, qd x 14 days, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2011-08-24
Velcade
Indication: Multiple Myeloma
Start date: 2011-08-24
Other drugs received by patient: Aspirin
Possible Dexamethasone side effects in 63 year old female
Reported by a physician from United States on 2012-03-23
Patient: 63 year old female, weighing 100.7 kg (221.5 pounds)
Reactions: Neurotoxicity, Chest Pain, Pulmonary Embolism, Multiple Myeloma, Pneumonitis, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxil
Dosage: 40 mg/m2, iv
Indication: Product Used FOR Unknown Indication
Dexamethasone
Dosage: 20 mg, ut dict after chemo 1 week later ; 40 mg
Indication: Product Used FOR Unknown Indication
Revlimid
Dosage: 25 mg, 1 in 1 d, po ; 10 mg, qd x 21 days, po ; 10 mg, 21 days on/7 days off, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-04-01
Revlimid
Dosage: 25 mg, 1 in 1 d, po ; 10 mg, qd x 21 days, po ; 10 mg, 21 days on/7 days off, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-12-16
Revlimid
Dosage: 25 mg, 1 in 1 d, po ; 10 mg, qd x 21 days, po ; 10 mg, 21 days on/7 days off, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-07-01
Other drugs received by patient: Biaxin; Coumadin; Flexeril; Colace (Docusate Sodium); Lidoderm; Prilosec; Prozac; Arixtra; Gabapentin; Vagifem; Vicodin; Zoledronic Acid; Heparin; Trazodone HCL; Zofran; Albuterol Sulfate; Dilaudid; Lorazepam
Possible Dexamethasone side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-23
Patient: 62 year old female
Reactions: NO Therapeutic Response, Monoclonal Immunoglobulin Present, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 25 mg, daily x 21 days, po
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-10-01
Dexamethasone
Dosage: 40 mg, weekly
Indication: Multiple Myeloma
Possible Dexamethasone side effects in male
Reported by a individual with unspecified qualification from United States on 2012-03-21
Patient: male
Reactions: Febrile Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Neulasta
Indication: non-Hodgkin's Lymphoma
Mabthera
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Dexamethasone
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Vincristine
Indication: non-Hodgkin's Lymphoma
Start date: 2012-02-17
End date: 2012-02-22
Other drugs received by patient: Fluconazole; MS Contin; Metoprolol Succinate; Valtrex; Ciprofloxacin
Possible Dexamethasone side effects in
Reported by a physician from Sweden on 2012-03-21
Patient:
Reactions: Haemorrhage, Pulmonary Embolism, Pyrexia, Skin Reaction, Somnolence, Peripheral Sensory Neuropathy, Constipation, Herpes Zoster, Herpes Simplex, Transient Ischaemic Attack, Type 1 Diabetes Mellitus, Peripheral Motor Neuropathy, Thrombocytopenia, Pneumonia, Vomiting, Nausea, Ischaemic Stroke, Toxicity To Various Agents, Anxiety, Cardiac Failure, Diarrhoea, Hallucination, Visual, Intestinal Gangrene, Vertigo, Haemorrhagic Stroke, Treatment Failure, Neutropenia, Neuralgia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Dexamethasone
Dosage: 40 milligram
Administration route: Oral
Thalidomide
Dosage: escalated by 50 mg every 3 weeks
Administration route: Oral
Possible Dexamethasone side effects in male
Reported by a consumer/non-health professional from United States on 2012-03-16
Patient: male, weighing 99.9 kg (219.7 pounds)
Reactions: Abdominal Pain, Tinnitus, Pain in Extremity, Hypertensive Heart Disease, Hyperglycaemia, Anaemia, Mental Status Changes, Pulmonary Embolism, Lactic Acidosis, Tinea Pedis, Cardio-Respiratory Arrest, Hepatomegaly, Dehydration, Pulmonary Oedema, Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Sodium Chloride
Dosage: 100 to 250 cc
Start date: 2011-01-31
End date: 2011-04-08
Cisplatin
Dosage: 1-5 x3; 35mg
Start date: 2011-01-31
End date: 2011-04-08
Dexamethasone Sodium Phosphate
Dosage: d 1-5 x3 cycle
Indication: Nausea
Start date: 2011-01-31
End date: 2011-04-06
Dexamethasone
Dosage: 4 tablet;
Indication: Vomiting
Start date: 2011-03-21
End date: 2011-03-25
Etoposide
Dosage: 230 milligram; 1-5 x4
Indication: Seminoma
Start date: 2011-01-31
End date: 2011-04-08
Other drugs received by patient: Ondansetron; Aprepitant; Mannitol; Palonosetron Hydrochloride
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-03-09
Patient: male, weighing 100.0 kg (220.0 pounds)
Reactions: Abdominal Pain, Tinnitus, Pain in Extremity, Anaemia, Hypertensive Heart Disease, Hyperglycaemia, Mental Status Changes, Pulmonary Embolism, Lactic Acidosis, Tinea Pedis, Hepatomegaly, Cardio-Respiratory Arrest, Dehydration, Pulmonary Oedema, Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Dexamethasone Sodium Phosphate
Indication: Prophylaxis of Nausea and Vomiting
Etoposide
Dosage: 230 mg once daily d 1-5 x 4 cycles
Indication: Seminoma
Start date: 2011-01-31
End date: 2011-04-08
Cisplatin
Dosage: 45 mg d 1-5 x 3 cycles; 35 mg on cycle 4
Indication: Seminoma
Start date: 2011-01-31
End date: 2011-04-08
Dexamethasone Sodium Phosphate
Indication: Vomiting
Dexamethasone
Dosage: 4 tablets (2 tablets twice daily)
Administration route: Oral
Indication: Vomiting
Start date: 2011-03-21
End date: 2011-03-25
Sodium Chloride
Dosage: 100 to 250 ml
Start date: 2011-01-31
End date: 2011-04-08
Dexamethasone Sodium Phosphate
Dosage: 10 mg d 1-5 x 3 cycles
Indication: Nausea
Start date: 2011-01-31
End date: 2011-04-06
Other drugs received by patient: Aloxi; Mannitol; Emend; Zofran
Possible Dexamethasone side effects in male
Reported by a physician from United States on 2012-03-05
Patient: male, weighing 99.9 kg (219.7 pounds)
Reactions: Abdominal Pain, Tinnitus, Pain in Extremity, Hypertensive Heart Disease, Hyperglycaemia, Anaemia, Pulmonary Embolism, Mental Status Changes, Lactic Acidosis, Tinea Pedis, Hepatomegaly, Cardio-Respiratory Arrest, Dehydration, Pulmonary Oedema, Neutropenia, Deep Vein Thrombosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 1-5 x3; 35mg
Start date: 2011-01-31
End date: 2011-04-08
Sodium Chloride
Dosage: 100 to 250 cc
Start date: 2011-01-31
End date: 2011-04-08
Dexamethasone
Dosage: 4 tablet;
Indication: Vomiting
Start date: 2011-03-21
End date: 2011-03-25
Dexamethasone Sodium Phosphate
Dosage: d 1-5 x3 cycle
Indication: Nausea
Start date: 2011-01-31
End date: 2011-04-06
Etoposide
Dosage: 230 milligram; 1-5 x4
Indication: Seminoma
Start date: 2011-01-31
End date: 2011-04-08
Other drugs received by patient: Mannitol; Aprepitant; Ondansetron; Palonosetron Hydrochloride
Possible Dexamethasone side effects in 72 year old male
Reported by a physician from United States on 2012-03-01
Patient: 72 year old male, weighing 83.0 kg (182.6 pounds)
Reactions: Electrocardiogram QT Prolonged, Abdominal Pain, Pulmonary Embolism, Mental Status Changes, Fatigue, Haematoma, Decreased Appetite, Anaemia, Hypotension, Blood Lactic Acid Increased, Staphylococcal Infection, Oliguria, Hypophagia, Dehydration, Septic Shock, Asthenia, Venous Occlusion, Deep Vein Thrombosis
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Temozolomide
Dosage: ; po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2010-02-22
Dexamethasone
Dosage: 4 mg;
Indication: Product Used FOR Unknown Indication
Start date: 2010-03-15
ABT-888
Dosage: 20 mg;qd;po
Administration route: Oral
Indication: Glioblastoma Multiforme
Start date: 2010-02-22
Other drugs received by patient: Multi-Vitamin; Zyflamend X; Ascorbic Acid; Colecaliciferol; Ascorbic Acid
Page 1 Next >>
|